Suchergebnisse - "Tibor Keler"

1

1522 Revitalizing systemic immune responses in progressive NSCLC using FLT3L and SBRT

von: Tibor Keler

2023, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
2

464 Clonal replacement of tumor-infiltrating CD8+ T cells by induction and activation of tumor-residing Batf3-dependent dendritic cells

von: Tibor Keler

2020, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
3

Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s

von: Takaaki Oba

2020, in: Nature Communications

Wird geladen...
4

The CD27/CD70 pathway negatively regulates visceral adipose tissue-resident Th2 cells and controls metabolic homeostasis

von: Kevin Englebert

2024, in: Cell Reports

Wird geladen...
5

M. tuberculosis-Initiated Human Mannose Receptor Signaling Regulates Macrophage Recognition and Vesicle Trafficking by FcRγ-Chain, Grb2, and SHP-1

von: Murugesan V.S. Rajaram

2017, in: Cell Reports

Wird geladen...
6

Flt3L-Mediated Expansion of Plasmacytoid Dendritic Cells Suppresses HIV Infection in Humanized Mice

von: Tram N.Q. Pham

2019, in: Cell Reports

Wird geladen...
7

CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response

von: Katherine A. Riccione

2018, in: OncoImmunology

Wird geladen...
8

Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering

von: Franziska Heckel

2022, in: Communications Biology

Wird geladen...
9

Tissue-specific modifier alleles determine Mertk loss-of-function traits

von: Yemsratch T Akalu

2022, in: eLife

Wird geladen...
10

CDX-585, a Bispecific Antibody with Dual Targeting of ILT4 and PD-1 Checkpoint Pathways

von: Michael B. Murphy

2023, in: Immuno

Wird geladen...
11

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

von: Malte Braunschweig

2015, in: Nature

Wird geladen...
12

Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors

von: Mario Sznol

2022, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
13

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

von: Johannes F Scheid

2016, in: Nature

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!